- Design
- Retrospective multicentre real-world cohort study
- Population
- 26 children under 18 with ANCA-associated vasculitis; 11 (42.3%) received therapeutic plasma exchange
- Primary outcome
- Clinical characteristics, indications and outcomes including Pediatric Vasculitis Activity Score
- Effect
- Activity score at diagnosis median 12 (plasma exchange) vs 7 (P = 0.004); fell from 12.0 to 4.5 after treatment (P = 0.007); persistent renal abnormality common; one death from catheter-related sepsis
Twenty-six children diagnosed with ANCA-associated vasculitis by EULAR/PRINTO/PRES criteria were reviewed across multiple centres; 11 (42.3%) received therapeutic plasma exchange alongside standard induction.
The two groups were not comparable, and the paper does not pretend otherwise. Children who received plasma exchange had substantially higher disease activity at diagnosis (median Pediatric Vasculitis Activity Score 12 against 7, P = 0.004), higher creatinine, lower estimated glomerular filtration rate, and almost all of the severe pulmonary, gastrointestinal, cardiovascular and cutaneous involvement in the series. Severe kidney disease was the primary indication.
After treatment, activity scores fell - median 12.0 to 4.5 (P = 0.007) - and most acute organ-threatening manifestations improved. But persistent renal abnormalities remained common in those with severe baseline kidney disease, and one child died of catheter-related Pseudomonas aeruginosa sepsis during treatment.
That last detail belongs in the decision. In adults, the evidence for plasma exchange in ANCA vasculitis has moved towards more selective use, and this series describes exactly that pattern in children: reserved for the sickest, associated with improvement in activity, and not rescuing kidneys that were already badly damaged. The line access itself carries risk in an immunosuppressed child, and in a series of 26 it accounted for the only death.
- Reserve plasma exchange for severe or refractory disease, which is how it was actually used here
- Do not expect recovery of kidney function that is already severely impaired at presentation
- Count the catheter as part of the risk of the intervention, not a separate logistical matter
- Record Pediatric Vasculitis Activity Score at diagnosis and after induction; it was the responsive measure here
- Twenty-six children across multiple centres - this describes practice, it does not evaluate it
Why it matters
It shows what selective use of plasma exchange actually looks like in children, and what it does not achieve.
Don't overread it
Retrospective with the treated group selected for severity - no comparison here can estimate the effect of plasma exchange.
The statistics, in plain English
The fall in activity score from 12.0 to 4.5 is a before-and-after comparison within the treated children, not a comparison against the children who did not receive plasma exchange - and every one of those children also received cyclophosphamide or rituximab with glucocorticoids, which would be expected to produce exactly this improvement. Comparing the two groups directly is not informative either, because the plasma exchange group was selected for being far sicker. With 26 patients, the single sepsis death gives a case fatality that cannot be meaningfully estimated but is a real event that would not appear at all in a smaller series.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.
Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for rheumatology, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free